106 related articles for article (PubMed ID: 29076602)
1. Diffusion tensor imaging marks dopaminergic and serotonergic lesions in the Parkinsonian monkey.
Météreau E; Beaudoin-Gobert M; Duperrier S; Thobois S; Tremblay L; Sgambato-Faure V
Mov Disord; 2018 Feb; 33(2):298-309. PubMed ID: 29076602
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of levodopa-induced dyskinesia: Insights from multimodal imaging and immunohistochemistry in non-human primates.
Beaudoin-Gobert M; Météreau E; Duperrier S; Thobois S; Tremblay L; Sgambato V
Neuroimage; 2018 Dec; 183():132-141. PubMed ID: 30102999
[TBL] [Abstract][Full Text] [Related]
3. Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate.
Beaudoin-Gobert M; Epinat J; Météreau E; Duperrier S; Neumane S; Ballanger B; Lavenne F; Liger F; Tourvielle C; Bonnefoi F; Costes N; Bars DL; Broussolle E; Thobois S; Tremblay L; Sgambato-Faure V
Brain; 2015 Sep; 138(Pt 9):2632-47. PubMed ID: 26117365
[TBL] [Abstract][Full Text] [Related]
4. Breathing new life into neurotoxic-based monkey models of Parkinson's disease to study the complex biological interplay between serotonin and dopamine.
Sgambato V
Prog Brain Res; 2021; 261():265-285. PubMed ID: 33785131
[TBL] [Abstract][Full Text] [Related]
5. Prior MDMA administration aggravates MPTP-induced Parkinsonism in macaque monkeys.
Millot M; Saga Y; Duperrier S; Météreau E; Beaudoin-Gobert M; Sgambato V
Neurobiol Dis; 2020 Feb; 134():104643. PubMed ID: 31689516
[TBL] [Abstract][Full Text] [Related]
6. Effect of MPTP on Serotonergic Neuronal Systems and Mitochondrial Complex I Activity in the Living Brain: A PET Study on Conscious Rhesus Monkeys.
Kanazawa M; Ohba H; Nishiyama S; Kakiuchi T; Tsukada H
J Nucl Med; 2017 Jul; 58(7):1111-1116. PubMed ID: 28280215
[TBL] [Abstract][Full Text] [Related]
7. Serotonergic innervation of the striatum in a nonhuman primate model of Parkinson's disease.
Jiménez-Sánchez L; Blesa J; Del Rey NL; Monje MHG; Obeso JA; Cavada C
Neuropharmacology; 2020 Jun; 170():107806. PubMed ID: 31589886
[TBL] [Abstract][Full Text] [Related]
8. Toxicity of MPTP on neurotransmission in three mouse models of Parkinson's disease.
Pain S; Gochard A; Bodard S; Gulhan Z; Prunier-Aesch C; Chalon S
Exp Toxicol Pathol; 2013 Jul; 65(5):689-94. PubMed ID: 23083629
[TBL] [Abstract][Full Text] [Related]
9. Estradiol and brain serotonin reuptake transporter in long-term ovariectomized parkinsonian monkeys.
Sánchez MG; Morissette M; Di Paolo T
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():170-7. PubMed ID: 23719069
[TBL] [Abstract][Full Text] [Related]
10. A non-human primate model for stable chronic Parkinson's disease induced by MPTP administration based on individual behavioral quantification.
Seo J; Lee Y; Kim BS; Park J; Yang S; Yoon HJ; Yoo J; Park HS; Hong JJ; Koo BS; Baek SH; Jeon CY; Huh JW; Kim YH; Park SJ; Won J; Ahn YJ; Kim K; Jeong KJ; Kang P; Lee DS; Lim SM; Jin YB; Lee SR
J Neurosci Methods; 2019 Jan; 311():277-287. PubMed ID: 30391524
[TBL] [Abstract][Full Text] [Related]
11. Changes in the rates of the tricarboxylic acid (TCA) cycle and glutamine synthesis in the monkey brain with hemiparkinsonism induced by intracarotid infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): studies by non-invasive 13C-magnetic resonance spectroscopy.
Kanamatsu T; Otsuki T; Tokuno H; Nambu A; Takada M; Okamoto K; Watanabe H; Umeda M; Tsukada Y
Brain Res; 2007 Nov; 1181():142-8. PubMed ID: 17919469
[TBL] [Abstract][Full Text] [Related]
12. Imaging Dopamine and Serotonin Systems on MPTP Monkeys: A Longitudinal PET Investigation of Compensatory Mechanisms.
Ballanger B; Beaudoin-Gobert M; Neumane S; Epinat J; Metereau E; Duperrier S; Broussolle E; Thobois S; Bonnefoi F; Tourvielle C; Lavenne F; Costes N; Lebars D; Zimmer L; Sgambato-Faure V; Tremblay L
J Neurosci; 2016 Feb; 36(5):1577-89. PubMed ID: 26843639
[TBL] [Abstract][Full Text] [Related]
13. SPECT imaging, immunohistochemical and behavioural correlations in the primate models of Parkinson's disease.
Ashkan K; Wallace BA; Mitrofanis J; Pollo C; Brard PY; Fagret D; Benabid AL
Parkinsonism Relat Disord; 2007 Jul; 13(5):266-75. PubMed ID: 17196871
[TBL] [Abstract][Full Text] [Related]
14. Brain structural changes in cynomolgus monkeys administered with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A longitudinal voxel-based morphometry and diffusion tensor imaging study.
Jeong HS; Lee SR; Kim JE; Lyoo IK; Yoon S; Namgung E; Chang KT; Kim BS; Yang S; Im JJ; Jeon S; Kang I; Ma J; Chung YA; Lim SM
PLoS One; 2018; 13(1):e0189804. PubMed ID: 29320500
[TBL] [Abstract][Full Text] [Related]
15. Effect of a chronic treatment with an mGlu5 receptor antagonist on brain serotonin markers in parkinsonian monkeys.
Morin N; Morissette M; Grégoire L; Di Paolo T
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():27-38. PubMed ID: 25046277
[TBL] [Abstract][Full Text] [Related]
16. The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study.
Blesa J; Pifl C; Sánchez-González MA; Juri C; García-Cabezas MA; Adánez R; Iglesias E; Collantes M; Peñuelas I; Sánchez-Hernández JJ; Rodríguez-Oroz MC; Avendaño C; Hornykiewicz O; Cavada C; Obeso JA
Neurobiol Dis; 2012 Oct; 48(1):79-91. PubMed ID: 22677034
[TBL] [Abstract][Full Text] [Related]
17. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
[TBL] [Abstract][Full Text] [Related]
18. Recovery of motor function and dopaminergic parameters in a mouse model of Parkinson's disease induced by co-administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and diethyldithiocarbamate.
Shimazu S; Takahata K; Tamashiro A; Yoneda F; Iida Y; Saji H
J Neural Transm (Vienna); 2003 Aug; 110(8):871-83. PubMed ID: 12898343
[TBL] [Abstract][Full Text] [Related]
19. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
[TBL] [Abstract][Full Text] [Related]
20. Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
Rojas P; Ruiz-Sánchez E; Rojas C; Ogren SO
Neuroscience; 2012 Oct; 223():246-57. PubMed ID: 22885234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
